Browsing by Subject "Treatment"
Now showing items 1-6 of 6
-
Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina
(Wolters Kluwer Health, Inc. All rights reserved, 2018-04-30)Abstract Background and aim Adherence to the Barcelona Clinic Liver Cancer (BCLC) staging algorithm for the treatment of hepatocellular carcinoma is challenging in the daily practice. We aimed to analyze adherence to ... -
Hipoglucemia en el recién nacido: muchas preguntas, pocas respuestas
(FUNDASAMIN (Fundación para la Salud Materno Infantil), 2020-12-01)La hipoglucemia es el trastorno metabólico más fre- cuente en el recién nacido. Es probablemente una de las pocas causas prevenibles de lesión cerebral. A pe- sar de esto, el manejo de la hipoglucemia se basó y ... -
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America
(American Society of Clinical Oncology, 2021-08)Abstract Purpose: We present a physician survey of the impact of 21-gene Breast Recurrence Score test results on treatment decisions in clinical practice in Latin America. Methods: This prospective survey enrolled ... -
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences.
(Elsevier B.V. ScienceDirect, 2016-03-01)During the last four decades, proliferative vitreoretinopathy (PVR) has defied the efforts of many researchers to prevent its occurrence or development. Thus, PVR is still the major complication following retinal detachment ... -
Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina.
(Press of International Journal of Ophthalmology, 2017-01-01)AIM: To review all cases of Vogt-Koyanagi-Harada (VKH) disease in an Inflammatory Eye Disease Service in Argentina and to describe the clinical profile and outcomes of treatment. METHODS: The records from patients ... -
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
(Wiley, 2019-01-13)Abstract Background & Aims: Data from Europe and North America have been published re‐ garding the risk of developing hepatocellular carcinoma (HCC) after treatment with direct antiviral agents (DAA). We proposed to ...